topics buy-american-act 
Patently-O
SEPTEMBER 26, 2022
American Axle (cert denied). Topics: Enablement / Written Description (All three are biotech / pharma): 3 Cases; Infringement (FDA Labeling): 1 Case; Anticipation (On Sale Bar): 1 Case; Double Patenting (Still the law?) Similarly, obviousness type double patenting has no grounding in the Patent Act. Wade (1972).
SpicyIP
AUGUST 30, 2021
Topical Highlight. Kedar concludes that the Court set a much-needed precedent, by settling that even a medical necessity induced by COVID cannot be a free-pass for the pharma-companies to blatantly infringe IP rights and later play victim by justifying their act under the pretext of public emergency. Sun Pharma v. Cipla Ltd. ,
Expert insights. Personalized for you.
125 
Let's personalize your content